News | Intra-Aortic Balloon Pumps (IABP) | March 31, 2023

Datascope/Getinge Issues New Recall of Certain Cardiosave Hybrid and Rescue IABPs for Risk of Unexpected Shutdown

According to a new release issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary of Getinge, is recalling Cardiosave Hybrid IABPs and Rescue IABPs because a communication loss between the executive processor printed circuit board assembly (PCBA) and the video generator PCBA may cause an unexpected shutdown

According to a new release issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary of Getinge, is recalling Cardiosave Hybrid IABPs and Rescue IABPs because a communication loss between the executive processor printed circuit board assembly (PCBA) and the video generator PCBA may cause an unexpected shutdown

March 31, 2023 — According to statement issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary of Getinge, is recalling Cardiosave Hybrid IABPs and Rescue IABPs because a communication loss between the executive processor printed circuit board assembly (PCBA) and the video generator PCBA may cause an unexpected shutdown. This shutdown will occur without warnings or alarms to alert the user. Once the error occurs, one or both of the PCBAs will need to be replaced for the device to work again.

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death.

Recalled Product

Product Name:

  • Cardiosave Hybrid Intra-Aortic Balloon Pump (IABP) and Cardiosave Rescue Intra-Aortic Balloon Pump (IABP)
  • Product Models:
  • Distribution Dates: March 6, 2012 to January 13, 2023
  • Devices Recalled in the U.S.: Estimated 4,502
  • Date Initiated by Firm: January 9, 2023

Device Use

The Cardiosave Hybrid Intra-Aortic Balloon Pump (IABP) and the Cardiosave Rescue IABP are electromechanical systems used to inflate and deflate intra-aortic balloons. These systems provide temporary support to the left ventricle through counter pulsation. Once the balloon is positioned in the aorta, the pump is set to work in synchrony with the electrocardiogram or arterial pressure waveform to make the balloon inflate and deflate at the right time during the cardiac cycle.

Cardiosave Intra-Aortic Balloon Pumps are indicated for acute coronary syndrome, cardiac and non-cardiac surgery, or complications of heart failure in adults. They are used in health care facilities.

Reason for Recall

Datascope, a subsidiary of Getinge, is recalling Cardiosave Hybrid IABPs and Rescue IABPs because a communication loss between the executive processor printed circuit board assembly (PCBA) and the video generator PCBA may cause an unexpected shutdown. This shutdown will occur without warnings or alarms to alert the user. Once the error occurs, one or both of the PCBAs will need to be replaced for the device to work again.

An unexpected pump shutdown and any interruption to therapy that occurs can lead to unstable blood flow (hemodynamic instability), organ damage and/or death, especially for people who are critically ill and most likely to receive therapy using these devices.

Datascope/Getinge reported 42 complaints about PCBA communication failures resulting in unexpected shutdowns. There are no reports of any injuries or deaths related to this issue.

Who May be Affected

  • People who receive circulatory support using a CardioSave Hybrid or Rescue IABP
  • Health care personnel providing care that includes the CardioSave Hybrid or Rescue IABP

What to Do

On February 7, 2023, Datascope/Getinge sent customers an Urgent Medical Device Correction letter. The letter offered the following clinical guidelines and user actions related to the PCBA communication failure as part of a list of several notifications.

PCBA Communication Failure Clinical User Actions

  • Use another IABP to continue therapy if an unexpected shutdown occurs.
  • If the device remains inoperable after a shutdown:
    • Remove it from patient care.
    • Contact a service representative to identify the cause and take necessary actions.

PCBA Communication Failure User Actions

  • Examine inventory immediately to identify any Cardiosave Hybrid and/or Rescue IABPs.
  • Ensure that all Cardiosave Intra-Aortic Balloon Pump users are aware of this notice and actions to perform.
  • Complete and sign the MEDICAL DEVICE CORRECTION – RESPONSE form included with the letter to acknowledge receipt of notification. Return the completed form to Datascope/Getinge by e-mailing a scanned copy to cardiosave-sdhl23.act@getinge.com or by faxing the form to 1-877-660-5841.
  • Distributors should forward the letter to any customers who received affected products.

Datascope/Getinge has developed a software correction to address this issue, and a service representative will contact customers to schedule installation of the software when it is available.

Contact Information

Customers with questions about this recall should contact their Datascope/Getinge representative or call Datascope/Getinge Technical Support at 1-888-943-8872, options 4, 2, 1, Monday through Friday, between the hours of 8:00 a.m. and 6:00 p.m. (Eastern Time Zone).

Additional Resources:

How do I report a problem?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using an online form, regular mail, or FAX.


Related Content

News | Intra-Aortic Balloon Pumps (IABP)

August 14, 2023 — The FDA has announced that Datascope/Maquet/Getinge is recalling the Cardiosave Hybrid and Rescue ...

Home August 14, 2023
Home
News | Intra-Aortic Balloon Pumps (IABP)

May 19, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces results of a third-party analysis showing that ...

Home May 19, 2023
Home
News | Intra-Aortic Balloon Pumps (IABP)

March 20, 2023 — According to a statement issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary ...

Home March 20, 2023
Home
News | Intra-Aortic Balloon Pumps (IABP)

January 25, 2023 — According to a new release from the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary ...

Home January 25, 2023
Home
Feature | Intra-Aortic Balloon Pumps (IABP)

The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Arrow AutoCAT 2 and AC3 Intra-Aortic ...

Home December 20, 2022
Home
News | Intra-Aortic Balloon Pumps (IABP)

October 26, 2022 — Abiomed (Nasdaq: ABMD) announces a new program to address healthcare disparities in underserved ...

Home October 26, 2022
Home
News | Intra-Aortic Balloon Pumps (IABP)

December 16, 2021 — Datascope/Getinge/Maquet has recalled the Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic ...

Home December 16, 2021
Home
News | Intra-Aortic Balloon Pumps (IABP)

November 2, 2021 — Datascope/Getinge/Maquet is recalling its Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pumps (IABP) ...

Home November 02, 2021
Home
Feature | Intra-Aortic Balloon Pumps (IABP)

July 24, 2019 — The U.S. Food and Drug Administration announced Maquet/Datascope is recalling all intra-aortic balloon ...

Home July 24, 2019
Home
News | Intra-Aortic Balloon Pumps (IABP)

November 5, 2018 — The U.S. Food and Drug Administration (FDA) is evaluating recent reports of Getinge's Maquet ...

Home November 05, 2018
Home
Subscribe Now